Zacks Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-364
| Closed | -$262K | – | 691 |
|
|
2023
Q2 | $262K | Sell |
364
-33
| -8% | -$23.7K | ﹤0.01% | 552 |
|
|
2023
Q1 | $326K | Sell |
397
-18
| -4% | -$14.8K | ﹤0.01% | 505 |
|
|
2022
Q4 | $299K | Sell |
415
-141
| -25% | -$102K | ﹤0.01% | 501 |
|
|
2022
Q3 | $383K | Sell |
556
-55
| -9% | -$37.9K | 0.01% | 456 |
|
|
2022
Q2 | $361K | Sell |
611
-13,232
| -96% | -$7.82M | 0.01% | 463 |
|
|
2022
Q1 | $9.67M | Buy |
13,843
+1,099
| +9% | +$768K | 0.13% | 142 |
|
|
2021
Q4 | $8.05M | Buy |
12,744
+964
| +8% | +$609K | 0.11% | 157 |
|
|
2021
Q3 | $7.13M | Buy |
11,780
+859
| +8% | +$520K | 0.11% | 159 |
|
|
2021
Q2 | $6.1M | Buy |
10,921
+806
| +8% | +$450K | 0.1% | 164 |
|
|
2021
Q1 | $4.79M | Buy |
+10,115
| New | +$4.79M | 0.09% | 178 |
|
|
2018
Q4 | – | Sell |
-594
| Closed | -$240K | – | 574 |
|
|
2018
Q3 | $240K | Buy |
+594
| New | +$240K | 0.01% | 482 |
|
|
2015
Q1 | – | Sell |
-1,203
| Closed | -$494K | – | 692 |
|
|
2014
Q4 | $494K | Buy |
+1,203
| New | +$494K | 0.02% | 416 |
|